Repurposing cancer drugs for malaria treatment

FHS
June 22, 2023
3:18 am

With malaria becoming increasingly drug-resistant, a team of UCF researchers is looking to use cancer drugs to accelerate the discovery of new life-saving therapies for the disease.

DOUGLAS Group achieves strong results and strategic progress in financial year 2023/24 – Biotech Investments

EQS-News: Douglas AG / Key word(s): Annual Results/Annual Report DOUGLAS Group achieves strong results and strategic progress in financial year 2023/24 19.12.2024 / 07:30 CET/CEST

December 20, 2024

Cybin Announces Renewed At-The-Market Equity Program of up to US$35 Million | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment

August 24, 2023

Bluebird in fundraising mode: A $150M public offering and a deal to get cash early from gene therapy sales

Facing a financial void it had hoped to be filled by a priority review voucher, bluebird bio is tapping two different sources to bring in

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.